JP2012515720A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515720A5 JP2012515720A5 JP2011546429A JP2011546429A JP2012515720A5 JP 2012515720 A5 JP2012515720 A5 JP 2012515720A5 JP 2011546429 A JP2011546429 A JP 2011546429A JP 2011546429 A JP2011546429 A JP 2011546429A JP 2012515720 A5 JP2012515720 A5 JP 2012515720A5
- Authority
- JP
- Japan
- Prior art keywords
- sorbate
- benzoate
- acid
- benzoic acid
- aminobenzoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14593109P | 2009-01-20 | 2009-01-20 | |
| US61/145,931 | 2009-01-20 | ||
| PCT/US2010/021420 WO2010085452A1 (en) | 2009-01-20 | 2010-01-19 | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012515720A JP2012515720A (ja) | 2012-07-12 |
| JP2012515720A5 true JP2012515720A5 (enExample) | 2013-02-28 |
| JP5675650B2 JP5675650B2 (ja) | 2015-02-25 |
Family
ID=42354348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011546429A Expired - Fee Related JP5675650B2 (ja) | 2009-01-20 | 2010-01-19 | 向精神薬の働きを向上させるソルビン酸、安息香酸及びその誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US9649304B2 (enExample) |
| EP (3) | EP2389187B1 (enExample) |
| JP (1) | JP5675650B2 (enExample) |
| CN (1) | CN102292094B (enExample) |
| AU (1) | AU2010206886B2 (enExample) |
| BR (1) | BRPI1007173A2 (enExample) |
| CA (2) | CA3037010A1 (enExample) |
| DK (2) | DK3006024T3 (enExample) |
| ES (2) | ES2615884T3 (enExample) |
| HR (2) | HRP20170089T1 (enExample) |
| MX (3) | MX353752B (enExample) |
| WO (1) | WO2010085452A1 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX353752B (es) | 2009-01-20 | 2018-01-26 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco. |
| WO2011017319A1 (en) * | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of treating disorders associated with protein polymerization |
| US9072772B2 (en) | 2009-11-05 | 2015-07-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods of treating disorders associated with protein aggregation |
| US8809617B2 (en) | 2009-11-05 | 2014-08-19 | The University of Pittsburgh—Of the Commonwealth System of Higher Education | Automated high-content live animal drug screening using C. elegans |
| JP5751109B2 (ja) * | 2011-09-20 | 2015-07-22 | ニプロ株式会社 | 生体試料中の馬尿酸およびメチル馬尿酸のそれぞれの濃度を測定する方法 |
| WO2014025814A1 (en) * | 2012-08-06 | 2014-02-13 | S1 Pharmaceuticals, Inc. | Treatment regimens |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| WO2014168727A1 (en) * | 2013-03-15 | 2014-10-16 | Shire Llc | Fixed dose combination treatment for schizophrenia |
| KR102162073B1 (ko) * | 2014-03-24 | 2020-10-07 | 가오슝 창 궁 메모리얼 하스피털 | 치매 또는 경도 인지 장애의 예방 또는 치료용 조성물의 제조에 사용하는 벤조산염의 용도 |
| JP7001593B2 (ja) | 2015-08-11 | 2022-01-19 | コグノア， インコーポレイテッド | 人工知能およびユーザ入力を用いて発達進度を判定するための方法および装置 |
| US11972336B2 (en) | 2015-12-18 | 2024-04-30 | Cognoa, Inc. | Machine learning platform and system for data analysis |
| US10653639B2 (en) | 2016-05-16 | 2020-05-19 | Cv Sciences, Inc. | Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction |
| CA3027290A1 (en) * | 2016-06-13 | 2017-12-21 | Syneurx International (Taiwan) Corp. | Use of lithium benzoate for treating central nervous system disorders |
| ES2936094T3 (es) * | 2016-06-13 | 2023-03-14 | Syneurx Int Taiwan Corp | Cocristales de benzoato de sodio y usos de los mismos |
| RU2765625C2 (ru) | 2016-06-13 | 2022-02-01 | Сайньюрекс Интернэшнл (Тайвань) Корп. | Сокристаллы бензоата лития и их применения |
| CA3037531A1 (en) * | 2016-09-23 | 2018-03-29 | Delpor, Inc. | Compositions for small molecule therapeutic agent compounds |
| US10336679B2 (en) * | 2016-10-24 | 2019-07-02 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| US11369579B2 (en) | 2016-10-24 | 2022-06-28 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| CN118609834A (zh) * | 2016-11-14 | 2024-09-06 | 科格诺亚公司 | 用于评估发育状况并提供覆盖度和可靠性控制的方法和装置 |
| TW201827051A (zh) * | 2016-12-02 | 2018-08-01 | 美商神經性分泌生物科學公司 | 戊苯那嗪（valbenazine）於治療精神分裂症或情感性精神分裂症之用途 |
| ES3001152T3 (es) | 2016-12-20 | 2025-03-04 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polisiloxano o poliisobutileno |
| PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
| AU2018219846A1 (en) | 2017-02-09 | 2019-09-12 | Cognoa, Inc. | Platform and system for digital personalized medicine |
| TWI626043B (zh) * | 2017-06-13 | 2018-06-11 | 心悅生醫股份有限公司 | 苯甲酸鋰用於治療中樞神經系統疾病的用途 |
| US11033512B2 (en) | 2017-06-26 | 2021-06-15 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
| JP6550426B2 (ja) * | 2017-07-26 | 2019-07-24 | カオシュン・チャン・グン・メモリアル・ホスピタル | 認知症または軽度認知障害を予防または治療する組成物を製造するための安息香酸塩の使用 |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| KR20250110361A (ko) | 2017-10-10 | 2025-07-18 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| US10098861B1 (en) * | 2017-10-24 | 2018-10-16 | Syneurx International (Taiwan) Corp. | Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof |
| US11826326B2 (en) * | 2017-11-22 | 2023-11-28 | Excelsior Pharmatech Labs | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
| JP7268026B2 (ja) | 2017-12-05 | 2023-05-02 | サノビオン ファーマシューティカルズ インク | 非ラセミ混合物およびその使用 |
| MX2020005517A (es) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Formas cristalinas y metodos de produccion de las mismas. |
| KR102802121B1 (ko) | 2018-06-20 | 2025-05-02 | 에르테에스 로만 테라피-시스테메 아게 | 아세나핀을 함유하는 경피 치료 시스템 |
| CN118806732A (zh) | 2018-06-20 | 2024-10-22 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| KR102051624B1 (ko) * | 2018-11-30 | 2019-12-02 | 아밀로이드솔루션 주식회사 | 트리플루프로마진 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 퇴행성 뇌질환 치료용 약학 조성물 |
| BR112021018770A2 (pt) | 2019-03-22 | 2022-02-15 | Cognoa Inc | Métodos e dispositivos de terapia digital personalizada |
| WO2020212951A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
| US11160758B2 (en) | 2019-06-04 | 2021-11-02 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| CN119949562A (zh) * | 2020-03-27 | 2025-05-09 | 深圳市合瑞生物科技有限公司 | 组合物及其制品 |
| CA3180941C (en) | 2020-06-01 | 2024-01-02 | Rajaram Samant | Novel synergistic medicinal compositions for treating dysfunctional d-serine signaling |
| US20240374544A1 (en) * | 2021-08-30 | 2024-11-14 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acid |
| CA3241282A1 (en) * | 2021-12-16 | 2023-06-22 | Kalipada PAHAN | Benzoic acid salts for treatment of nervous system injuries and disorders |
| US20240120050A1 (en) * | 2022-10-07 | 2024-04-11 | Insight Direct Usa, Inc. | Machine learning method for predicting a health outcome of a patient using video and audio analytics |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3498989A (en) * | 1969-04-16 | 1970-03-03 | American Home Prod | Certain 8-substituted-2-alkyl-3-benzoyl esters of ecgonine and derivatives thereof |
| US3870715A (en) | 1972-03-09 | 1975-03-11 | Nikolaus R Hansl | Substituted amino ethyl meta benzoic acid esters |
| US4041174A (en) * | 1974-08-16 | 1977-08-09 | Rom-Amer Pharmaceuticals, Ltd. | Method of treating depression |
| US5204356A (en) | 1985-07-24 | 1993-04-20 | Glaxo Group Limited | Treatment of anxiety |
| US6150354A (en) | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
| GB8819494D0 (en) * | 1988-08-16 | 1988-09-21 | Ucb Sa | Use of 2-amino-4-morpholino-6-propyl-1 3 5-triazines for preparation of psychotropic medicaments |
| US6746678B1 (en) | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
| FR2700117B1 (fr) | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens. |
| DE4340273A1 (de) * | 1993-11-26 | 1995-06-01 | Karla Dr Lehmann | Arzneimittel zur Prophylaxe des Morbus Alzheimer und zur Verhütung des Fortschreitens dieser Erkrankung |
| US5453425A (en) | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
| US6362226B2 (en) * | 1999-12-08 | 2002-03-26 | Vanderbilt University | Modulation of in vivo glutamine and glycine levels in the treatment of autism |
| US20040156872A1 (en) * | 2000-05-18 | 2004-08-12 | Elan Pharma International Ltd. | Novel nimesulide compositions |
| AU8174001A (en) | 2000-07-21 | 2002-02-05 | Lundbeck & Co As H | Novel compounds and their use as glycine transport inhibitors |
| WO2002014286A1 (en) | 2000-08-14 | 2002-02-21 | Teva Pharmaceutical Industries Ltd. | Preparation of risperidone |
| US20030185754A1 (en) | 2001-01-16 | 2003-10-02 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| MXPA03006321A (es) | 2001-01-16 | 2003-10-06 | Genset Sa | Tratamiento de trastornos del sistema nervioso central usando antagonistas de d-aminoacido oxidasa y d-aspartato oxidasa. |
| US20030162825A1 (en) * | 2001-11-09 | 2003-08-28 | Sepracor Inc. | D-amino acid oxidase inhibitors for learning and memory |
| AU2002339696A1 (en) | 2001-12-03 | 2003-06-17 | Genset S.A. | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors |
| US20070053976A1 (en) * | 2002-05-17 | 2007-03-08 | Eisai R & D Management Co., Ltd. | Novel combination of drugs as antidepressant |
| US7053122B2 (en) * | 2002-08-09 | 2006-05-30 | Pfizer Inc | Therapeutic use of aryl amino acid derivatives |
| US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
| GEP20094759B (en) * | 2002-10-24 | 2009-08-25 | Merz Pharma Gmbh & Co Kgaa | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| WO2004065348A1 (en) * | 2003-01-23 | 2004-08-05 | Pfizer Products Inc. | Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof |
| JP2007502332A (ja) * | 2003-05-30 | 2007-02-08 | マイクロバイア インコーポレイテッド | 記憶および認知保護法 |
| EP1628660A4 (en) | 2003-06-02 | 2010-06-02 | Samaritan Pharmaceuticals Inc | METHOD AND COMPOSITIONS FOR MODULATING THE CORTISOL SERUM MIRRORS |
| CN101798291A (zh) * | 2003-12-29 | 2010-08-11 | 塞普拉科公司 | 苯并[d]异噁唑-3-醇DAAO抑制剂 |
| WO2005070938A1 (en) * | 2004-01-27 | 2005-08-04 | Synthon B.V. | Stable salts of olanzapine |
| CA2556870C (en) * | 2004-02-18 | 2014-01-28 | Timothy J. Barberich | Dopamine-agonist combination therapy for improving sleep quality |
| JP4756031B2 (ja) | 2004-03-24 | 2011-08-24 | メルク・シャープ・エンド・ドーム・コーポレイション | ヘテロアリールピペリジングリシン輸送体インヒビター |
| JP2007536228A (ja) * | 2004-05-06 | 2007-12-13 | サイデックス・インコーポレイテッド | セルトラリンおよびスルホアルキルエーテルシクロデキストリンを含有するテイストマスク製剤 |
| WO2006096439A2 (en) | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
| WO2006129160A2 (en) * | 2005-06-01 | 2006-12-07 | Aurobindo Pharma Limited | Stable aqueous oral solution of risperidone |
| US20110045065A1 (en) | 2005-07-11 | 2011-02-24 | Ashok Vasantray Vyas | Substance having antioxidant, geroprotective and anti-ischemic activity and method for the preparation thereof |
| US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
| EP1976495A2 (en) * | 2006-01-06 | 2008-10-08 | Aarhus Universitet | Compounds acting on the serotonin transporter |
| GB0603181D0 (en) * | 2006-02-17 | 2006-03-29 | Merck Sharp & Dohme | Treatment of neurodegenerative and psychiatric diseases |
| US20080045512A1 (en) * | 2006-08-09 | 2008-02-21 | Pfizer Inc. | Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]-pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane |
| WO2008034087A2 (en) | 2006-09-15 | 2008-03-20 | Xenoport, Inc. | Treating schizophrenia with combinations of levodopa and an antipsychotic agent |
| MX353752B (es) | 2009-01-20 | 2018-01-26 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco. |
-
2010
- 2010-01-19 MX MX2011007712A patent/MX353752B/es active IP Right Grant
- 2010-01-19 JP JP2011546429A patent/JP5675650B2/ja not_active Expired - Fee Related
- 2010-01-19 EP EP10733788.3A patent/EP2389187B1/en active Active
- 2010-01-19 EP EP15192644.1A patent/EP3006024B1/en active Active
- 2010-01-19 HR HRP20170089TT patent/HRP20170089T1/hr unknown
- 2010-01-19 AU AU2010206886A patent/AU2010206886B2/en not_active Ceased
- 2010-01-19 MX MX2017002152A patent/MX380715B/es unknown
- 2010-01-19 MX MX2017002151A patent/MX374638B/es unknown
- 2010-01-19 WO PCT/US2010/021420 patent/WO2010085452A1/en not_active Ceased
- 2010-01-19 CN CN2010800050053A patent/CN102292094B/zh active Active
- 2010-01-19 ES ES10733788.3T patent/ES2615884T3/es active Active
- 2010-01-19 DK DK15192644.1T patent/DK3006024T3/da active
- 2010-01-19 US US12/689,957 patent/US9649304B2/en not_active Expired - Fee Related
- 2010-01-19 ES ES15192644T patent/ES2731228T3/es active Active
- 2010-01-19 EP EP15192647.4A patent/EP3006023B1/en active Active
- 2010-01-19 DK DK10733788.3T patent/DK2389187T3/en active
- 2010-01-19 CA CA3037010A patent/CA3037010A1/en active Pending
- 2010-01-19 CA CA2750028A patent/CA2750028C/en active Active
- 2010-01-19 BR BRPI1007173A patent/BRPI1007173A2/pt not_active IP Right Cessation
-
2014
- 2014-11-24 US US14/552,298 patent/US9675604B2/en active Active
-
2017
- 2017-01-19 US US15/409,775 patent/US10149845B2/en active Active
- 2017-01-19 US US15/409,655 patent/US10039730B2/en active Active
-
2018
- 2018-11-21 US US16/197,674 patent/US11529342B2/en active Active
-
2019
- 2019-05-21 HR HRP20190933TT patent/HRP20190933T1/hr unknown